Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease.
Marthey, L
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease. [electronic resource] - Journal of Crohn's & colitis Apr 2016 - 395-401 p. digital
Publication Type: Journal Article
1876-4479
10.1093/ecco-jcc/jjv227 doi
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
CTLA-4 Antigen--immunology
Colectomy
Colon--pathology
Enterocolitis--chemically induced
Female
Humans
Immunotherapy--adverse effects
Inflammatory Bowel Diseases--chemically induced
Ipilimumab
Male
Melanoma--therapy
Middle Aged
Young Adult
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease. [electronic resource] - Journal of Crohn's & colitis Apr 2016 - 395-401 p. digital
Publication Type: Journal Article
1876-4479
10.1093/ecco-jcc/jjv227 doi
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
CTLA-4 Antigen--immunology
Colectomy
Colon--pathology
Enterocolitis--chemically induced
Female
Humans
Immunotherapy--adverse effects
Inflammatory Bowel Diseases--chemically induced
Ipilimumab
Male
Melanoma--therapy
Middle Aged
Young Adult